Analytical Data
-
Gene name
ZNF75A
-
简介
The ZNF75A protein appears to be a potential influencer of transcriptional regulation, suggesting that it may play a role in shaping cellular function through gene expression control. Although the specific mechanisms and target genes affected by ZNF75A are not fully understood, its multifunctional nature in transcriptional regulation implies potential effects on a variety of cellular pathways. ZNF75A Protein, Human (His) is the recombinant human-derived ZNF75A protein, expressed by E. coli , with N-6*His labeled tag.
- Application
-
Alternative Names
Zinc Finger Protein 75A; ZNF75A
-
Species
Human
-
Source
E. coli
-
Tag
N-6*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96N20
-
Expression Region
S58-K162
-
Protein Length
Partial
-
Molecular Weight
14 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZNF75A, a member of the zinc-finger protein family, plays a crucial role in various biological processes, including gene regulation, cellular differentiation, and response to stress. The gene is characterized by its multiple zinc-finger motifs, which facilitate DNA binding and protein-protein interactions, thus influencing transcriptional control of target genes. Recent studies have linked ZNF75A to several pathological conditions, including cancer, where its expression levels may affect tumor progression and metastasis. Additionally, ZNF75A has been shown to interact with key signaling pathways, making it a potential target for therapeutic interventions. Given its significance, the recombinant expression of ZNF75A has garnered attention as a means to study its functional properties and interactions in vitro. By producing ZNF75A as a recombinant protein, researchers can gain insights into its structural characteristics, binding affinities, and possible regulatory mechanisms in cellular contexts. This approach not only aids in elucidating the biological roles of ZNF75A but also paves the way for exploring its potential in clinical applications, such as targeted therapies for diseases where ZNF75A is implicated. As such, the investigation of ZNF75A through recombinant protein technology represents a promising avenue for advancing our understanding of this important transcription factor and its contributions to health and disease.
